Influenza vaccine is available in limited supplies and administered
in priority as recommended by the Ministry of Health and Long Term Care
Please note that High Dose vaccine for 65+ is in extremely
short supply and may be periodically unavailable during the early
release period (October 12 - Nov 1)
The general public release will be the week of
Immunization of High-Risk Groups
Per the National Advisory Committee on Immunization (NACI), individuals in the following four groups are particularly recommended to receive the influenza vaccine:
- Individuals at high risk of influenza-related complications or who are more likely to require hospitalization:
- All pregnant women
- People who are residents of nursing homes or other chronic care facilities
- People ≥ 65 years of age
- All children 6 months to 4 years of age
- Indigenous peoples
- Adults or children 6 months of age and over with chronic health conditions as follows:
- Cardiac or pulmonary disorders
- Diabetes mellitus or other metabolic disease
- Conditions or medication which compromise the immune system (due to underlying disease, therapy or both)
- Renal disease
- Anemia or hemoglobinopathy
- Neurologic or neurodevelopment conditions
- Morbid obesity (body mass index of ≥ 40)
- Children and adolescents (6 months to 18 years) undergoing treatment with acetylsalicylic acid for long periods
- Individuals capable of transmitting influenza to those listed in #1 and/or to infants under 6 months of age:
- Health care workers and other care providers in facilities and community settings
- Household contacts (adults and children) of individuals at high risk of influenza related complications
- Persons who provide care to children ≤ 4 years of age
- Members of a household expecting a newborn during the influenza season
- Those who provide services within a closed or relatively closed setting to persons at high risk (e.g., crew on a ship)
- People who provide essential community services
- Poultry industry workers
To reduce the risk of severe illness that could potentially arise from co-infection with COVID-19 and influenza, individuals who are at high risk of severe COVID-19 related illness or those capable of transmitting influenza to those at high risk of severe and critical illness related to COVID-19 are particularly recommended to receive the influenza vaccine this fall.
Janzen's Pharmacy locations have pharmacists that have completed additional training that allows those pharmacists to administer influenza vaccinations to the public.
Pharmacists may only administer vaccine to those aged 2 and older.
Pharmacists are unable to vaccinate clients with severe neurological conditions, or clients who have had a reaction to a component of the vaccine. Although egg allergies are no longer a contraindication to influenza vaccination, pharmacists are not permitted to offer the vaccine to those clients with those types of allergies.
Janzen's Pharmacy continues to offer the services of Nurse Practitioners to our clients. For those who are unable to obtain influenza vaccinations via a trained pharmacist for the conditions outlined above, our nurse practitioners can offer the vaccine by appointment to our regular pharmacy clients. Our Nurse Practitioners can also provide high-dose vaccine to clients aged 65+ when availability permits.
For regular clients of Janzen's Pharmacy who may be physically prohibited from accessing the vaccine in the pharmacy, we offer house calls. Our house-call service is limited to those clients who utilize Janzen's Pharmacy as their sole and primary pharmacy with an active medication profile. However this is limited based on vaccine availability. We recommend to obtain the vaccine whenever possible as soon as possible.
After the General Release of the influenza vaccine our Nurse Practitioners will hold some general clinics for the public, as per the guidance from the Ministry of Health & Long Term Care. The general release is expected to be on or about the first week of November.
If you are a Janzen's community partner organization please click here